Betz Stephen F.
Insider CIK 1886575 · CRNX Chief Scientific Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 60,000 | $62.39 | $3.74M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 87,000 | $41.49 | $3.61M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 110,000 | $65.36 | $7.19M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 65,000 | $48.14 | $3.13M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 90,514 | $83.09 | $7.52M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 74,540 | $75.72 | $5.64M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 56,250 | $59.81 | $3.36M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 47,000 | $41.21 | $1.94M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 85,000 | $69.71 | $5.93M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 15,000 | $61.81 | $927.1K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 77,000 | $64.98 | $5.00M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 58,286 | $85.00 | $4.95M | 79,650 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 79,650 | $85.00 | $6.77M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 47,000 | $41.21 | $1.94M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 65,000 | $48.14 | $3.13M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 87,000 | $41.49 | $3.61M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 110,000 | $65.36 | $7.19M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 77,000 | $64.98 | $5.00M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 15,000 | $61.81 | $927.1K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 85,000 | $69.71 | $5.93M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 60,000 | $62.39 | $3.74M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 56,250 | $59.81 | $3.36M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 74,540 | $75.72 | $5.64M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 90,514 | $83.09 | $7.52M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 79,650 | $85.00 | $6.77M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 58,286 | $85.00 | $4.95M | 79,650 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2026-03-16 | 2026-03-18 | 4,241 | $37.77 | $160.2K | 137,101 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2026-03-16 | 2026-03-18 | 6,371 | $37.11 | $236.4K | 141,342 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2026-02-23 | 2026-02-25 | 47,000 | — | $0 | 47,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award | 2026-02-23 | 2026-02-25 | 30,000 | — | $0 | 147,713 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise deriv | 2025-12-26 | 2025-12-29 | 18,000 | — | $0 | 90,514 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise | 2025-12-26 | 2025-12-29 | 18,000 | $1.91 | $34.4K | 117,713 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise deriv | 2025-06-12 | 2025-06-16 | 71,525 | — | $0 | 108,514 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise deriv | 2025-06-12 | 2025-06-16 | 16,645 | — | $0 | 58,198 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2025-06-12 | 2025-06-16 | 97,483 | $32.23 | $3.14M | 99,713 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise | 2025-06-12 | 2025-06-16 | 71,525 | $1.91 | $136.6K | 180,551 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise | 2025-06-12 | 2025-06-16 | 16,645 | $9.28 | $154.5K | 197,196 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2025-03-19 | 2025-03-21 | 291 | $34.83 | $10.1K | 108,588 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2025-03-19 | 2025-03-21 | 5,479 | $34.17 | $187.2K | 108,879 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2025-02-20 | 2025-02-24 | 65,000 | — | $0 | 65,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award | 2025-02-20 | 2025-02-24 | 43,000 | — | $0 | 114,358 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise deriv | 2024-12-16 | 2024-12-18 | 2,331 | — | $0 | 180,039 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise | 2024-12-16 | 2024-12-18 | 2,331 | $1.91 | $4.5K | 71,358 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2024-09-10 | 2024-09-12 | 1,035 | $51.50 | $53.3K | 68,576 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2024-08-26 | 2024-08-28 | 3,000 | $53.19 | $159.6K | 69,611 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2024-08-12 | 2024-08-14 | 3,000 | $47.68 | $143.0K | 72,611 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2024-07-25 | 2024-07-26 | 3,000 | $53.43 | $160.3K | 75,611 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2024-07-10 | 2024-07-12 | 3,000 | $48.55 | $145.7K | 78,611 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2024-06-25 | 2024-06-26 | 3,000 | $45.37 | $136.1K | 80,643 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2024-06-10 | 2024-06-11 | 3,000 | $43.86 | $131.6K | 83,643 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2024-05-28 | 2024-05-30 | 3,000 | $47.49 | $142.5K | 86,643 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2024-05-10 | 2024-05-14 | 3,000 | $49.43 | $148.3K | 89,643 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | F Tax w/h | 2024-03-18 | 2024-03-20 | 3,655 | $38.14 | $139.4K | 92,643 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2024-03-04 | 2024-03-06 | 87,000 | — | $0 | 87,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award | 2024-03-04 | 2024-03-06 | 23,000 | — | $0 | 96,298 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2024-01-25 | 2024-01-26 | 3,000 | $37.26 | $111.8K | 73,298 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2024-01-10 | 2024-01-12 | 3,000 | $37.65 | $113.0K | 76,298 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2023-12-26 | 2023-12-27 | 3,000 | $35.89 | $107.7K | 79,298 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2023-12-11 | 2023-12-13 | 3,000 | $32.87 | $98.6K | 82,298 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2023-11-27 | 2023-11-29 | 3,000 | $31.84 | $95.5K | 85,298 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | F Tax w/h | 2023-03-16 | 2023-03-17 | 1,410 | $17.12 | $24.1K | 86,879 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2023-03-01 | 2023-03-03 | 110,000 | — | $0 | 110,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award | 2023-03-01 | 2023-03-03 | 23,600 | — | $0 | 88,289 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2023-02-01 | 2023-02-03 | 3,126 | $19.59 | $61.2K | 64,689 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2023-01-25 | 2023-01-27 | 8,336 | $21.07 | $175.6K | 67,815 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2023-01-17 | 2023-01-19 | 3,126 | $18.00 | $56.3K | 76,151 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2023-01-03 | 2023-01-05 | 3,126 | $18.35 | $57.4K | 79,277 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2022-12-15 | 2022-12-19 | 3,126 | $16.00 | $50.0K | 82,403 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2022-12-01 | 2022-12-05 | 3,126 | $17.84 | $55.8K | 84,968 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2022-11-15 | 2022-11-17 | 3,126 | $18.72 | $58.5K | 88,094 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2022-11-01 | 2022-11-03 | 3,126 | $18.52 | $57.9K | 91,220 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2022-10-17 | 2022-10-19 | 3,126 | $17.73 | $55.4K | 94,346 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2022-10-03 | 2022-10-05 | 3,126 | $19.64 | $61.4K | 97,472 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2022-09-15 | 2022-09-19 | 4,168 | $21.01 | $87.6K | 100,598 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2022-09-07 | 2022-09-09 | 1,042 | $21.00 | $21.9K | 104,766 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2022-09-01 | 2022-09-06 | 3,126 | $18.59 | $58.1K | 105,808 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | J Other | 2022-05-20 | 2022-09-06 | 1,336 | $11.02 | $14.7K | 108,934 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2022-05-02 | 2022-05-04 | 3,247 | $20.10 | $65.3K | 107,598 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2022-04-18 | 2022-04-21 | 5,664 | $25.81 | $146.2K | 110,845 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2022-04-04 | 2022-04-06 | 9,000 | $23.97 | $215.7K | 116,509 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2022-04-01 | 2022-04-01 | 4,164 | $21.80 | $90.8K | 125,509 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2022-03-31 | 2022-04-01 | 4,164 | $21.06 | $87.7K | 129,673 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2022-03-15 | 2022-03-17 | 3,123 | $18.94 | $59.1K | 133,837 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2022-03-01 | 2022-03-02 | 3,123 | $19.73 | $61.6K | 136,960 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2022-02-28 | 2022-03-02 | 77,000 | — | $0 | 77,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award | 2022-02-28 | 2022-03-02 | 16,500 | — | $0 | 140,083 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2022-02-15 | 2022-02-17 | 3,123 | $18.64 | $58.2K | 123,583 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2022-02-01 | 2022-02-03 | 3,123 | $18.79 | $58.7K | 126,706 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2022-01-18 | 2022-01-20 | 4,168 | $23.29 | $97.1K | 128,875 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2022-01-03 | 2022-01-06 | 7,168 | $28.02 | $200.8K | 133,043 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2021-12-28 | 2021-12-30 | 3,000 | $27.95 | $83.8K | 140,211 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2021-12-15 | 2021-12-17 | 5,668 | $24.14 | $136.8K | 143,211 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2021-12-01 | 2021-12-03 | 5,668 | $27.38 | $155.2K | 148,879 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2021-11-16 | 2021-11-17 | 1,500 | $27.97 | $42.0K | 154,547 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2021-11-15 | 2021-11-17 | 5,668 | $26.75 | $151.6K | 156,047 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2021-11-08 | 2021-11-09 | 3,900 | $28.42 | $110.8K | 161,715 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2021-11-05 | 2021-11-09 | 12,600 | $27.95 | $352.2K | 165,615 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2021-11-01 | 2021-11-03 | 5,668 | $24.79 | $140.5K | 178,215 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2021-10-27 | 2021-10-28 | 3,000 | $24.00 | $72.0K | 183,883 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2021-10-21 | 2021-10-25 | 1,042 | $21.10 | $22.0K | 186,883 | SEC↗ |